Your browser doesn't support javascript.
loading
PPARγ lipodystrophy mutants reveal intermolecular interactions required for enhancer activation.
Madsen, Maria Stahl; Broekema, Marjoleine F; Madsen, Martin Rønn; Koppen, Arjen; Borgman, Anouska; Gräwe, Cathrin; Thomsen, Elisabeth G K; Westland, Denise; Kranendonk, Mariette E G; Koerkamp, Marian Groot; Hamers, Nicole; Bonvin, Alexandre M J J; Pittol, José M Ramos; Natarajan, Kedar Nath; Kersten, Sander; Holstege, Frank C P; Monajemi, Houshang; van Mil, Saskia W C; Vermeulen, Michiel; Kragelund, Birthe B; Cassiman, David; Mandrup, Susanne; Kalkhoven, Eric.
Affiliation
  • Madsen MS; Functional Genomics and Metabolism Research Unit, Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark.
  • Broekema MF; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Madsen MR; Department of Human Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Koppen A; Functional Genomics and Metabolism Research Unit, Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark.
  • Borgman A; Gubra, Hørsholm, Denmark.
  • Gräwe C; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Thomsen EGK; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Westland D; Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University Nijmegen, 6525, Nijmegen, GA, The Netherlands.
  • Kranendonk MEG; Department of Biology, University of Copenhagen, Copenhagen, Denmark.
  • Koerkamp MG; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Hamers N; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Bonvin AMJJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Pittol JMR; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Natarajan KN; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Kersten S; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Holstege FCP; Faculty of Science-Chemistry, Bijvoet Centre for Biomolecular Research, Utrecht University, Utrecht, The Netherlands.
  • Monajemi H; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • van Mil SWC; Institute of Biochemistry and Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria.
  • Vermeulen M; Functional Genomics and Metabolism Research Unit, Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark.
  • Kragelund BB; Division of Human Nutrition, Nutrition, Metabolism and Genomics Group, Wageningen University, Wageningen, The Netherlands.
  • Cassiman D; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Mandrup S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Kalkhoven E; Internal Medicine, Rijnstate Hospital, Arnhem, The Netherlands.
Nat Commun ; 13(1): 7090, 2022 11 19.
Article in En | MEDLINE | ID: mdl-36402763
ABSTRACT
Peroxisome proliferator-activated receptor γ (PPARγ) is the master regulator of adipocyte differentiation, and mutations that interfere with its function cause lipodystrophy. PPARγ is a highly modular protein, and structural studies indicate that PPARγ domains engage in several intra- and inter-molecular interactions. How these interactions modulate PPARγ's ability to activate target genes in a cellular context is currently poorly understood. Here we take advantage of two previously uncharacterized lipodystrophy mutations, R212Q and E379K, that are predicted to interfere with the interaction of the hinge of PPARγ with DNA and with the interaction of PPARγ ligand binding domain (LBD) with the DNA-binding domain (DBD) of the retinoid X receptor, respectively. Using biochemical and genome-wide approaches we show that these mutations impair PPARγ function on an overlapping subset of target enhancers. The hinge region-DNA interaction appears mostly important for binding and remodelling of target enhancers in inaccessible chromatin, whereas the PPARγ-LBDRXR-DBD interface stabilizes the PPARγRXRDNA ternary complex. Our data demonstrate how in-depth analyses of lipodystrophy mutants can unravel molecular mechanisms of PPARγ function.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: PPAR gamma / Lipodystrophy Limits: Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: PPAR gamma / Lipodystrophy Limits: Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2022 Document type: Article Affiliation country:
...